1. WHO. World Malaria Report. Geneva: World Health Organization; 2016.
2. Bricaire F, Danis M, Gentilini M. Paludisme et grossesse. Cahiers. Santé. 2008;63:289–92.
3. Bamba S, Séré A, Nikiéma R, Halidou T, Thiéba B, Dao B, et al. Traitement préventif intermittent à la sulfadoxine–pyriméthamine du paludisme chez les femmes enceintes: efficacité et observance dans deux hôpitaux urbains du Burkina Faso. Pan Afr Med J. 2013;14:105.
4. Rupérez M, González R, Mombo-Ngoma G, Kabanywanyi AM, Sevene E, Ouédraogo S, et al. Mortality, morbidity, and developmental outcomes in infants born to women who received either mefloquine or sulfadoxine–pyrimethamine as intermittent preventive treatment of malaria in pregnancy: a cohort study. PLoS Med. 2016;13:e1001964.
5. OMS. Chimioprévention Du Paludisme Saisonnier. 2013. p. 1–45. Available from:
http://www.who.int/malaria/areas/preventive_therapies/children/fr/
. Accessed 9 June 2017.